{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:02:29Z","timestamp":1771599749045,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Globally, the trajectory of COVID-19 has been shaped by viral evolution, widespread vaccination and immunity from prior infections. We assessed the epidemiological and clinical patterns of COVID-19 in Lebanon between 2020 and 2024, identified the predominant SARS-CoV-2 clades and evaluated risk factors for COVID-19 associated mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This multicenter prospective study enrolled 1302 patients hospitalized with COVID-19 in Lebanon between November 2020 and October 2024. Multivariate logistic regression was used to determine predictors of COVID-19 associated mortality. Whole genome sequencing (WGS) was utilized to investigate the genomic epidemiology of SARS-CoV-2 and infer viral interactions between Lebanon and other countries. Multiple sequence alignment and phylogenetic analysis were conducted using the augur pipeline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A progressive and significant reduction in severe outcomes, including pneumonia and mortality was observed throughout the study period. Pneumonia (AOR, 6.714; CI, 4.140\u201310.888;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001) and age \u2265 60\u2009years (AOR, 6.051; CI, 2.190\u201316.723;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001) were identified as independent predictors of COVID-19 mortality. Moreover, receiving 3 doses of a COVID-19 vaccine significantly reduced the odds of mortality (AOR, 0.229; CI, 0.108\u20130.486;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Genomic analysis revealed multiple introductions of the same SARS-CoV-2 clades into Lebanon, which seeded local transmission chains.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The transition of COVID-19 from pandemic to endemic in Lebanon was associated with reduced disease severity. Vaccination remains essential, particularly in older adult patients who are at high risk of mortality. Moreover, early diagnosis and management of pneumonia are crucial, given its association with COVID-19 mortality. Furthermore, WGS has proven valuable in tracking the local evolution of SARS-CoV-2 and its impact on clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-12635-w","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:04:14Z","timestamp":1769580254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genomic and clinical epidemiology of SARS-CoV-2 in Lebanon: a prospective multicenter study 2020\u20132024"],"prefix":"10.1186","volume":"26","author":[{"given":"Fatima","family":"Dakroub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celina F.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habib","family":"Alkalamouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagham","family":"Hamzah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Hourani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Haddara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samar","family":"Dalle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dima","family":"Khreis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsy","family":"Tawil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silma","family":"Baasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab El","family":"Zein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayse","family":"Naser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawan","family":"Korman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maher","family":"Sraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yara","family":"Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kawthar","family":"Faour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadim","family":"Tfaily","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghenwa","family":"Dakdouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rouba","family":"Shaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imad","family":"Chokr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Breish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada M.","family":"Melhem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine Abou","family":"Fayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Zaraket","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewan M.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan M.","family":"Matar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghassan S.","family":"Dbaibo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"issue":"7798","key":"12635_CR1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020 Mar 1;579(7798):270\u201373.","journal-title":"Nature"},{"issue":"10440","key":"12635_CR2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"M Naghavi","year":"2024","unstructured":"Naghavi M, Ong KL, Aali A, Ababneh HS, Abate YH, Abbafati C, et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021. A systematic analysis for the global burden of disease study 2021. Lancet. 2024 May 18;403(10440):2100\u201332.","journal-title":"The Lancet"},{"key":"12635_CR3","doi-asserted-by":"crossref","unstructured":"Budinger GRS, Misharin AV, Ridge KM, Singer BD, Wunderink RG. Distinctive features of severe SARS-CoV-2 pneumonia. J Clin Invest. 2021 July 15;131(14).","DOI":"10.1172\/JCI149412"},{"issue":"1","key":"12635_CR4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","volume":"24","author":"G Deng","year":"2020","unstructured":"Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44, 672 patients with COVID-19. Crit Care. 2020 Apr 28;24(1):179.","journal-title":"Crit Care"},{"issue":"1","key":"12635_CR5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41479-024-00144-w","volume":"16","author":"S Tchakerian","year":"2024","unstructured":"Tchakerian S, Besnard N, Brunot V, Moulaire V, Benchabane N, Platon L, et al. Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves. Pneumonia (Nathan). 2024 Nov 5;16(1):27.","journal-title":"Pneumonia (Nathan)"},{"key":"12635_CR6","doi-asserted-by":"crossref","unstructured":"Hengkrawit K, Thananon J, Telapol K, Chiewchalermsri C. Clinical characteristics and outcomes of hospitalized COVID-19 patients with different variants of SARS-CoV-2 in a tertiary care hospital, Thailand. Trop Med Infect Disease [Internet]. 2024;9(11). Available from: https:\/\/www.mdpi.com\/2414-6366\/9\/11\/266.","DOI":"10.3390\/tropicalmed9110266"},{"issue":"2","key":"12635_CR7","doi-asserted-by":"crossref","first-page":"106272","DOI":"10.1016\/j.ijantimicag.2020.106272","volume":"57","author":"\u00c1 Nagy","year":"2021","unstructured":"Nagy \u00c1, Pongor S, Gy\u0151rffy B. Different mutations in SARS-CoV-2 associate with severe and mild outcome. Int J Antimicrob Agents. 2021 Feb;57(2):106272.","journal-title":"Int J Antimicrob Agents"},{"key":"12635_CR8","doi-asserted-by":"crossref","unstructured":"Stirrup O, Boshier F, Venturini C, Guerra-Assun\u00e7\u00e3o JA, Alcolea-Medina A, Beckett A, et al. SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study. BMJ Open Respir Res. 2021 Sept;8(1).","DOI":"10.1136\/bmjresp-2021-001029"},{"key":"12635_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijid.2022.04.050","volume":"120","author":"S Bhakta","year":"2022","unstructured":"Bhakta S, Sanghavi DK, Johnson PW, Kunze KL, Neville MR, Wadei HM, et al. Clinical and laboratory profiles of the SARS-CoV-2 Delta variant compared with pre-Delta variants. Int J Infect Dis. 2022 July 1;120:88\u201395.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"12635_CR10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1186\/s12879-023-08714-x","volume":"23","author":"N Radhakrishnan","year":"2023","unstructured":"Radhakrishnan N, Liu M, Idowu B, Bansari A, Rathi K, Magar S, et al. Comparison of the clinical characteristics of SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) infected patients from a single hospitalist service. BMC Infect Dis. 2023 Oct 31;23(1):747.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"12635_CR11","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1021\/acs.jcim.1c01451","volume":"62","author":"J Chen","year":"2022","unstructured":"Chen J, Wang R, Gilby NB, Wei GW. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance. J Chem Inf Model. 2022 Jan 24;62(2):412\u201322.","journal-title":"J Chem Inf Model"},{"issue":"11","key":"12635_CR12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/jcmm.17747","volume":"27","author":"M Arabi","year":"2023","unstructured":"Arabi M, Al-Najjar Y, Mhaimeed N, Salameh MA, Paul P, AlAnni J, et al. Severity of the Omicron SARS-CoV-2 variant compared with the previous lineages: a systematic review. J Cell Mol Med. 2023 June;27(11):1443\u201364.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"12635_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12920-023-01443-9","volume":"16","author":"H AlKalamouni","year":"2023","unstructured":"AlKalamouni H, Abou Hassan FF, Bou Hamdan M, Page AJ, Lott M, Matthews M, et al. Genomic surveillance of SARS-CoV-2 in COVID-19 vaccinated healthcare workers in Lebanon. BMC Med Genomics. 2023 Jan 27;16(1):14.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"12635_CR14","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1038\/s41598-024-84140-6","volume":"15","author":"J H\u00f6ppner","year":"2025","unstructured":"H\u00f6ppner J, Maier C, Schlegtendal A, Hoffmann A, Petersmann A, L\u00fccke T, et al. Long-term effects of SARS-CoV-2 infection and vaccination in a population-based pediatric cohort. Sci Rep. 2025 Jan 23;15(1):2921.","journal-title":"Sci Rep"},{"issue":"1","key":"12635_CR15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1080\/22221751.2022.2069516","volume":"11","author":"WJ Seo","year":"2022","unstructured":"Seo WJ, Kang J, Kang HK, Park SH, Koo HK, Park HK, et al. Impact of prior vaccination on clinical outcomes of patients with COVID-19. Emerg Microbes Infect. 2022 Dec;11(1):1316\u201324.","journal-title":"Emerg Microbes Infect"},{"issue":"12","key":"12635_CR16","doi-asserted-by":"crossref","first-page":"e2546822","DOI":"10.1001\/jamanetworkopen.2025.46822","volume":"8","author":"L Semenzato","year":"2025","unstructured":"Semenzato L, Le Vu S, Botton J, Bertrand M, Jabagi MJ, Drouin J, et al. COVID-19 mRNA vaccination and 4-year all-cause mortality among adults aged 18 to 59 years in France. JAMA Network Open. 2025 Dec 4;8(12):e2546822\u20132546822.","journal-title":"JAMA Network Open"},{"key":"12635_CR17","doi-asserted-by":"crossref","unstructured":"Lopez Bernal J, Andrews N, Gower C, Robertson C, Stowe J, Tessier E, et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study. BMJ [Internet]. 2021;373. Available from: https:\/\/www.bmj.com\/content\/373\/bmj.n1088.","DOI":"10.1136\/bmj.n1088"},{"key":"12635_CR18","doi-asserted-by":"crossref","first-page":"123610","DOI":"10.1016\/j.lfs.2025.123610","volume":"371","author":"M Azeem","year":"2025","unstructured":"Azeem M, Cancemi P, Mukhtar F, Marino S, Peri E, Di Prima G, et al. Efficacy and limitations of SARS-CoV-2 vaccines - a systematic review. Life Sci. 2025 June 15;371:123610.","journal-title":"Life Sci"},{"issue":"4","key":"12635_CR19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.2478\/jtim-2023-0122","volume":"11","author":"J Xie","year":"2023","unstructured":"Xie J, Ye F, Deng X, Tang Y, Liang JY, Huang X, et al. Circular RNA: a promising new star of vaccine. J Transl Int Med. 2023 Dec;11(4):372\u201381.","journal-title":"J Transl Int Med"},{"issue":"5","key":"12635_CR20","doi-asserted-by":"crossref","first-page":"2045853","DOI":"10.1080\/21645515.2022.2045853","volume":"18","author":"K Dhama","year":"2022","unstructured":"Dhama K, Dhawan M, Tiwari R, Emran TB, Mitra S, Rabaan AA, et al. COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges. Hum Vaccin Immunother. 2022 Nov 30;18(5):2045853.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"12635_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41577-022-00687-3","volume":"22","author":"CE Wagner","year":"2022","unstructured":"Wagner CE, Saad-Roy CM, Grenfell BT. Modelling vaccination strategies for COVID-19. Nat Rev Immunol. 2022 Mar 1;22(3):139\u201341.","journal-title":"Nat Rev Immunol"},{"key":"12635_CR22","unstructured":"World Health Organization. Global epidemiological surveillance standards for influenza [Internet]. 2013 [cited 2025 Sept 18]. [Geneva: World Health Organization]. 73 p. Available from: https:\/\/iris.who.int\/handle\/10665\/311268."},{"issue":"6","key":"12635_CR23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/irv.12335","volume":"9","author":"J Puig-Barber\u00e0","year":"2015","unstructured":"Puig-Barber\u00e0 J, Tormos A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. The global influenza hospital surveillance Network (GIHSN): a new platform to describe the epidemiology of severe influenza. Influenza Other Respir Viruses. 2015 Nov;9(6):277\u201386.","journal-title":"Influenza Other Respir Viruses"},{"key":"12635_CR24","unstructured":"Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens."},{"issue":"4","key":"12635_CR25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/molbev\/mst010","volume":"30","author":"K Katoh","year":"2013","unstructured":"Katoh K, Standley DM. MAFFT multiple sequence alignment Software version, 7: improvements in Performance and usability. Mol Biol Evol. 2013 Apr 1;30(4):772\u201380.","journal-title":"Mol Biol Evol"},{"issue":"5","key":"12635_CR26","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/molbev\/msaa015","volume":"37","author":"BQ Minh","year":"2020","unstructured":"Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD, von Haeseler A, et al. IQ-TREE 2: new models and efficient Methods for phylogenetic inference in the genomic Era. Mol Biol Evol. 2020 May 1;37(5):1530\u201334.","journal-title":"Mol Biol Evol"},{"issue":"1","key":"12635_CR27","doi-asserted-by":"crossref","first-page":"vex042","DOI":"10.1093\/ve\/vex042","volume":"4","author":"P Sagulenko","year":"2018","unstructured":"Sagulenko P, Puller V, Neher RA. TreeTime: maximum-likelihood phylodynamic analysis. Virus Evol. 2018 Jan 1;4(1):vex042.","journal-title":"Virus Evol"},{"issue":"1","key":"12635_CR28","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/2041-210X.12628","volume":"8","author":"G Yu","year":"2017","unstructured":"Yu G, Smith DK, Zhu H, Guan Y, Lam TTY. Ggtree: an r package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods In Ecol Evol. 2017 Jan 1;8(1):28\u201336.","journal-title":"Methods In Ecol Evol"},{"issue":"19","key":"12635_CR29","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, Gu L, Eils R, Schlesner M, Brors B. Circlize implements and enhances circular visualization in R. Bioinformatics. 2014 Oct 1;30(19):2811\u201312.","journal-title":"Bioinformatics"},{"key":"12635_CR30","volume-title":"Statement on the fifteenth meeting of the IHR (2005) emergency committee on the COVID-19 pandemic","author":"WHO","year":"2023","unstructured":"WHO. Statement on the fifteenth meeting of the IHR (2005) emergency committee on the COVID-19 pandemic. 2023 May."},{"issue":"20","key":"12635_CR31","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024, Oct 3;187(20):5500\u201329.","journal-title":"Cell"},{"issue":"5","key":"12635_CR32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/mr-2024-0013","volume":"4","author":"M Guo","year":"2024","unstructured":"Guo M, Shang S, Li M, Cai G, Li P, Chen X, et al. Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis\/mechanisms of long COVID. Med Rev (2021). 2024 Oct;4(5):367\u201383.","journal-title":"Med Rev (2021)"},{"issue":"1","key":"12635_CR33","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1515\/mr-2024-0030","volume":"5","author":"AG Ewing","year":"2025","unstructured":"Ewing AG, Salamon S, Pretorius E, Joffe D, Fox G, Bilodeau S, et al. Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology. Med Rev (2021). 2025 Feb;5(1):66\u201375.","journal-title":"Med Rev (2021)"},{"issue":"2","key":"12635_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/ID9.0000000000000081","volume":"3","author":"D Tian","year":"2023","unstructured":"Tian D, Pan Y, Ge Z, Kong X, Zhang Y, Zhang Q, et al. Difference of clinical characteristics in patients with Omicron and Delta variants of SARS-CoV-2 in Beijing, China. Infect Dis Immun. 2023 Apr;3(2):75\u201382.","journal-title":"Infect Dis Immun"},{"key":"12635_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lansea.2023.100348","author":"A Karuniawati","year":"2024","unstructured":"Karuniawati A, Pasaribu AP, Lazarus G, Irawany V, Nusantara DU, Sinto R, et al. Characteristics and clinical outcomes of patients with pre-delta, delta and omicron SARS-CoV-2 infection in Indonesia (2020-2023): a multicentre prospective cohort study. The Lancet Reg Health - Southeast Asia [Internet]. 2024, Mar, 1. 3[cited 2025 July 5];22. Available from: https:\/\/doi.org\/10.1016\/j.lansea.2023.100348.","journal-title":"The Lancet Reg Health - Southeast Asia"},{"issue":"10","key":"12635_CR36","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.chom.2023.08.003","volume":"31","author":"T Kehrer","year":"2023","unstructured":"Kehrer T, Cupic A, Ye C, Yildiz S, Bouhaddou M, Crossland NA, et al. Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis. Cell Host Microbe. 2023 Oct 11;31(10):1668\u201384.e12.","journal-title":"Cell Host Microbe"},{"issue":"7902","key":"12635_CR37","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui KPY, Ho JCW, Chun CM, Chun NK, Ching RHH, Ling LK, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022 Mar 1;603(7902):715\u201320.","journal-title":"Nature"},{"key":"12635_CR38","doi-asserted-by":"crossref","unstructured":"Liu Y, Rockl\u00f6v J. The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med. 2022 May 31;29(3).","DOI":"10.1093\/jtm\/taac037"},{"issue":"3","key":"12635_CR39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s15010-024-02223-y","volume":"52","author":"D Hattab","year":"2024","unstructured":"Hattab D, Amer MFA, Al-Alami ZM, Bakhtiar A. SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants. Infection. 2024 June;52(3):767\u201386.","journal-title":"Infection"},{"issue":"Suppl 2","key":"12635_CR40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00117-023-01147-2","volume":"63","author":"Z Pingping","year":"2023","unstructured":"Pingping Z, Yanyu Z, Xuri S, Qiming H, Yi W, Guoliang T. Comparison between original SARS-CoV-2 strain and omicron variant on thin-section chest CT imaging of COVID-19 pneumonia. Radiologie (Heidelb). 2023 Nov;63(Suppl 2):55\u201363.","journal-title":"Radiologie (Heidelb)"},{"issue":"3","key":"12635_CR41","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1016\/S2468-2667(22)00337-1","volume":"8","author":"N Imai","year":"2023","unstructured":"Imai N, Rawson T, Knock ES, Sonabend R, Elmaci Y, Perez-Guzman PN, et al. Quantifying the effect of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study. Lancet Public Health. 2023;8(3):e174\u201383.","journal-title":"The Lancet Public Health"},{"issue":"4","key":"12635_CR42","doi-asserted-by":"crossref","first-page":"100048","DOI":"10.1016\/j.jcvp.2021.100048","volume":"1","author":"F Dakroub","year":"2021","unstructured":"Dakroub F, Fakhredine S, Yassine M, Dayekh A, Jaber R, Fadel A, et al. A retrospective analysis of 902 hospitalized COVID-19 patients in Lebanon: clinical epidemiology and risk factors. J Clin Virol Plus. 2021 Dec;1(4):100048.","journal-title":"J Clin Virol Plus"},{"issue":"2","key":"12635_CR43","doi-asserted-by":"crossref","first-page":"102632","DOI":"10.1016\/j.jiph.2024.102632","volume":"18","author":"OR Abodunrin","year":"2025","unstructured":"Abodunrin OR, Olagunju MT, Huang X, Wang J, Hu Z, Shen C. Regional risk factors associated with adverse outcomes of COVID-19 infection among the older adult: a systematic review and meta-analysis. J Infect Public Health. 2025 Feb 1;18(2):102632.","journal-title":"J Infect Public Health"},{"issue":"1","key":"12635_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s41479-024-00144-w","volume":"16","author":"S Tchakerian","year":"2024","unstructured":"Tchakerian S, Besnard N, Brunot V, Moulaire V, Benchabane N, Platon L, et al. Epidemiology, clinical and biological characteristics, and prognosis of critically ill COVID 19 patients: a single-center experience through 4 successive waves. Pneumonia. 2024 Nov 5;16(1):27.","journal-title":"Pneumonia"},{"key":"12635_CR45","doi-asserted-by":"crossref","unstructured":"Singh P, Anand A, Rana S, Kumar A, Goel P, Kumar S, et al. Impact of COVID-19 vaccination: a global perspective. Front Public Health [Internet]. 2024;11-2023. Available from: https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2023.1272961.","DOI":"10.3389\/fpubh.2023.1272961"},{"key":"12635_CR46","doi-asserted-by":"crossref","unstructured":"Marron L, Mateo-Urdiales A, O\u2019Donnell J, Robinson E, Domegan L. Estimating the impact of the COVID-19 vaccination programme in Ireland: December 2021-March 2023. Eur J Public Health. 2024. 1923 Nov;1;34(Suppl_3): ckae144.","DOI":"10.1093\/eurpub\/ckae144.1923"},{"issue":"1","key":"12635_CR47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s43168-024-00275-0","volume":"18","author":"SM Wafy","year":"2024","unstructured":"Wafy SM, Saman MO, Ahmed MK. Predictors of mortality of hospitalized COVID-19 pneumonia patients in university hospital. Egypt J Bronchol. 2024 Mar 26;18(1):22.","journal-title":"The Egypt J Bronchol"},{"issue":"2","key":"12635_CR48","doi-asserted-by":"crossref","first-page":"102529","DOI":"10.1016\/j.jiac.2024.09.018","volume":"31","author":"M Mineshita","year":"2025","unstructured":"Mineshita M, Nishine H, Handa H, Inoue T, Ishibashi Y, Kawahata K, et al. 90-day outcomes in patients with severe COVID-19 pneumonia treated with invasive mechanical ventilation. J Infect Chemother. 2025 Feb 1;31(2):102529.","journal-title":"J Infect Chemother"},{"issue":"2","key":"12635_CR49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5603\/ARM.a2021.0036","volume":"89","author":"M Mahendra","year":"2021","unstructured":"Mahendra M, Nuchin A, Kumar R, Shreedhar S, Mahesh PA. Predictors of mortality in patients with severe COVID-19 pneumonia - a retrospective study. Adv Respir Med. 2021;89(2):135\u201344.","journal-title":"Adv Respir Med"},{"issue":"1","key":"12635_CR50","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1038\/s41598-024-55697-z","volume":"14","author":"K Ikenouchi","year":"2024","unstructured":"Ikenouchi K, Takahashi D, Mandai S, Watada M, Koyama S, Hoshino M, et al. Impact of COVID-19 versus other pneumonia on in-hospital mortality and functional decline among Japanese dialysis patients: a retrospective cohort study. Sci Rep. 2024 Mar 2;14(1):5177.","journal-title":"Sci Rep"},{"issue":"3","key":"12635_CR51","first-page":"317","volume":"12","author":"F Zhang","year":"2024","unstructured":"Zhang F, Li T, Bai Y, Liu J, Qin J, Wang A, et al. Treatment strategies with combined agency against severe viral pneumonia in patients with advanced cancer. J Transl Int Med. 2024 June;12(3):317\u201320.","journal-title":"J Transl Int Med"},{"key":"12635_CR52","doi-asserted-by":"crossref","unstructured":"Forin E, Galli F, Molina Saldarriaga FJ, Motos A, Misuraca S, Barbeta E, et al. Immunosuppressed patients with severe COVID-19 pneumonia: clinical characteristics and outcomes. Eur Respir Soc. 62(suppl 67):PA5093.","DOI":"10.1183\/13993003.congress-2023.PA5093"},{"issue":"1","key":"12635_CR53","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1038\/s41467-022-32536-1","volume":"13","author":"E Parker","year":"2022","unstructured":"Parker E, Anderson C, Zeller M, Tibi A, Havens JL, Laroche G, et al. Regional connectivity drove bidirectional transmission of SARS-CoV-2 in the Middle East during travel restrictions. Nat Commun. 2022 Aug 15;13(1):4784.","journal-title":"Nat Commun"},{"key":"12635_CR54","doi-asserted-by":"crossref","first-page":"605702","DOI":"10.3389\/fbioe.2020.605702","volume":"8","author":"Z Habli","year":"2020","unstructured":"Habli Z, Saleh S, Zaraket H, Khraiche ML. COVID-19 in-vitro diagnostics: state-of-the-art and challenges for rapid, scalable, and high-accuracy screening. Front Bioeng Biotechnol. 2020;8:605702.","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"12635_CR55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41746-022-00661-2","volume":"5","author":"DK Nurputra","year":"2022","unstructured":"Nurputra DK, Kusumaatmaja A, Hakim MS, Hidayat SN, Julian T, Sumanto B, et al. Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition. npj Digit Med. 2022 Aug 16;5(1):115.","journal-title":"npj Digit Med"},{"issue":"2","key":"12635_CR56","doi-asserted-by":"crossref","first-page":"116902","DOI":"10.1016\/j.diagmicrobio.2025.116902","volume":"113","author":"N Sultana","year":"2025","unstructured":"Sultana N, Biswas PP, Resma TI, Fatema N, Sharmin R, Sweety AA, et al. Evaluating saliva for SARS-CoV-2 detection: a practical alternative. Diagnostic Microbiol Infect Disease. 2025 Oct 1;113(2):116902.","journal-title":"Diagnostic Microbiol Infect Disease"},{"issue":"16","key":"12635_CR57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.15585\/mmwr.mm7316a2","volume":"73","author":"SE Smith-Jeffcoat","year":"2023","unstructured":"Smith-Jeffcoat SE, Mellis AM, Grijalva CG, Talbot HK, Schmitz J, Lutrick K, et al. SARS-CoV-2 viral shedding and rapid antigen test Performance - respiratory virus transmission Network, November 2022-May MMWR Morb Mortal Wkly Rep. 2023;73(16):365\u201371. 2024 Apr 25.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"12635_CR58","first-page":"299","volume":"12","author":"S Kang","year":"2024","unstructured":"Kang S, Zheng R. Distribution of the causes of fever of unknown origin in China, 2013-2022. J Transl Int Med. 2024 June;12(3):299\u2013307.","journal-title":"J Transl Int Med"},{"issue":"7","key":"12635_CR59","doi-asserted-by":"crossref","first-page":"ofac223","DOI":"10.1093\/ofid\/ofac223","volume":"9","author":"D Souverein","year":"2022","unstructured":"Souverein D, van Stralen K, van Lelyveld S, van Gemeren C, Haverkort M, Snijders D, et al. Initial severe acute respiratory syndrome coronavirus 2 viral load is associated with disease severity: a retrospective cohort study. Open Forum Infect Dis. 2022 July;9(7):ofac223.","journal-title":"Open Forum Infect Dis"},{"issue":"7821","key":"12635_CR60","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","volume":"584","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020 Aug;584(7821):430\u201336.","journal-title":"Nature"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12635-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12635-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:05:07Z","timestamp":1771596307000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12635-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12635"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12635-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the World Medical Association Declaration of Helsinki in 2013. The study was approved by the American University of Beirut Institutional Review Board (IRB) (protocol number: BIO-2018\u20130501). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed written consent was obtained from all patients included in the study, or from their legal representatives when patients were unable to provide consent. All collected samples were de-identified and assigned a unique study code. To maintain confidentiality, data were stored on a password-protected database in the CIDR that is accessible only to the IRB-approved study members.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"G. Dbaibo reports receiving research grants to his institution, serving on advisory boards, and receiving honoraria for lectures from Pfizer, MSD, Sanofi, and GSK. H. Zaraket is an employee and shareholder of Roche Products Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or material discussed in the manuscript","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"424"}}